Sino Biological,Inc. (SHE:301047)
China · Delayed Price · Currency is CNY 70.57
+2.23 (3.26%)
Mar 27, 2026, 4:00 PM EDT
Sino Biological,Inc. Revenue
Sino Biological,Inc. had revenue of 186.99M CNY in the quarter ending September 30, 2025, with 17.39% growth. This brings the company's revenue in the last twelve months to 660.17M, up 3.92% year-over-year. In the year 2024, Sino Biological,Inc. had annual revenue of 613.67M, down -5.06%.
Revenue (ttm)
660.17M
Revenue Growth
+3.92%
P/S Ratio
13.00
Revenue / Employee
646.59K
Employees
1,021
Market Cap
8.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 613.67M | -32.72M | -5.06% |
| Dec 31, 2023 | 646.39M | 71.79M | 12.49% |
| Jan 1, 2023 | 574.60M | -390.67M | -40.47% |
| Jan 1, 2022 | 965.27M | -631.02M | -39.53% |
| Dec 31, 2020 | 1.60B | 1.42B | 782.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Youcare Pharmaceutical Group | 2.45B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 2.06B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.94B |
| Nanjing Vazyme Biotech | 1.38B |
| Shanghai Medicilon | 1.08B |
| Bio-Thera Solutions | 933.69M |
| Daan Gene | 765.48M |
| Zhejiang Ausun Pharmaceutical | 751.12M |